Rabeprazole: Known uses and market status in India
Summary
The TxGNN deep-learning model (score ≥ 0.99) produced candidates for Rabeprazole, but every candidate that can be traced to a source is already a known use. There is therefore currently no new predicted indication for this drug. The two known uses are relations recorded in the knowledge graph, and no approval was found for either.
Quick overview
Item
Content
New predicted indications
None (all traceable model candidates are known uses)
Known uses among model candidates
2
Evidence level
Not applicable
India Market Status
Listed in a compiled Indian medicine price dataset (at least 20) – CDSCO approval status is not included in this data
Number of Listed Products
at least 20
Known uses among the model’s candidates
Approved (supported by a licence or label)
Indication
Source
none
none
Related to an approved indication (same disease category)
Indication
Approved category
none
none
Relations recorded in the knowledge graph (no approval found)
Indication
Smouldering systemic mastocytosis
lymphoadenopathic mastocytosis with eosinophilia
India Market Information
Licence
Product
Dosage form
Status
191472
Rowet 20mg Tablet
strip of 10 tablets
Valid
198837
Rastik-IT Capsule SR
strip of 10 capsule sr
Valid
96400
Gasorab 20mg Tablet
strip of 10 tablets
Valid
199186
Rabicred IV 20mg Injection
vial of 1 Injection
Valid
198012
Rabiamp 20mg Injection
vial of 1 Injection
Valid
242288
Wagus IT 20mg/150mg Capsule SR
strip of 10 capsule sr
Valid
191336
Ravezole 20mg Tablet
strip of 10 tablets
Valid
84872
Fast 20 Tablet
strip of 10 tablets
Valid
185636
Rabinta 20mg Tablet
strip of 10 tablets
Valid
86126
Far 20mg Tablet
strip of 10 tablets
Valid
249587
Zobit 20mg Injection
vial of 1 Injection
Valid
189919
Rabdon Tablet
strip of 10 tablets
Valid
184495
Rabeloc 20 Tablet
strip of 10 tablets
Valid
107407
Hotrab 20mg Tablet
strip of 10 tablets
Valid
186854
Rabeteo 20mg Tablet
strip of 10 tablets
Valid
190876
Rabiton 20mg Injection
vial of 1 Injection
Valid
197163
Rabiprez 20mg Injection
vial of 1 Injection
Valid
225512
Tivazol 20mg Tablet
strip of 10 tablets
Valid
140164
Miraz DSR 20mg Tablet
strip of 10 tablet sr
Valid
184873
Rablet 10 Tablet
strip of 15 tablets
Valid
Only part of the licence list is held in the data; the list may be incomplete.
Safety Considerations
Knowledge-graph contraindication signals (from drug-disease relationships, not label text): liver disease, gallbladder disease, osteoporosis, postmenopausal osteoporosis, bone fracture.
Drug Interactions: 486 interactions were identified. Examples of Major interactions include acalabrutinib and atazanavir. Examples of Moderate interactions include amikacin, amphotericin B formulations, amphetamine, aprepitant, armodafinil, apalutamide and bosutinib. Minor interactions include acetylsalicylic acid and axitinib.
Please refer to the package insert for warnings and contraindications.
Disclaimer
This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.